Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
Advanced Science · 2024-05 · 11 (17)
DOI: 10.1002/advs.202308298 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 17.02.2024. Verfasst von Shi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Eng…. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Atherosclerosis, Magnetic Iron Oxide Nanoparticles. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 270 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Atherosclerosis, a multifaceted chronic inflammatory disease, has a profound impact on cardiovascular health. However, the critical limitations of atherosclerosis management include the delayed detection of advanced stages, the intricate assessment of plaque stability, and the absence of efficacious therapeutic strategies. Nanotheranostic based on nanotechnology offers a novel paradigm for addressing these challenges by amalgamating advanced imaging capabilities with targeted therapeutic interventions. Meanwhile, iron oxide nanoparticles have emerged as compelling candidates for theranostic applications in atherosclerosis due to their magnetic resonance imaging capability and biosafety. This review delineates the current state and prospects of iron oxide nanoparticle‐based nanotheranostics in the realm of atherosclerosis, including pivotal aspects of atherosclerosis development, the pertinent targeting strategies involved in disease pathogenesis, and the diagnostic and therapeutic roles of iron oxide nanoparticles. Furthermore, this review provides a comprehensive overview of theranostic nanomedicine approaches employing iron oxide nanoparticles, encompassing chemical therapy, physical stimulation therapy, and biological therapy. Finally, this review proposes and discusses the challenges and prospects associated with translating these innovative strategies into clinically viable anti‐atherosclerosis interventions. In conclusion, this review offers new insights into the future of atherosclerosis theranostic, showcasing the remarkable potential of iron oxide‐based nanoparticles as versatile tools in the battle against atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Engineering, Southeast University, Nanjing, 210009, P. R. China.
- School of Medicine, Nanjing University, Nanjing, 210093, P. R. China.
ORCID-Profile: Hongliang He, Yu Zhang, Ning Gu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Wang, S., He, H., Mao, Y., Zhang, Y., & Gu, N. (2024). Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles. Advanced Science, 11(17). https://doi.org/10.1002/advs.202308298
Vancouver
Wang S, He H, Mao Y, Zhang Y, Gu N. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles. Advanced Science. 2024;11(17). doi:10.1002/advs.202308298
BibTeX
@article{Wang2024,
author = {Wang, Shi and He, Hongliang and Mao, Yu and Zhang, Yu and Gu, Ning},
title = {Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {17},
doi = {10.1002/advs.202308298}
}
EUVIMED